155 related articles for article (PubMed ID: 15679413)
61. Intraductal dysplasia: a premalignant lesion of the prostate.
McNeal JE; Bostwick DG
Hum Pathol; 1986 Jan; 17(1):64-71. PubMed ID: 3943853
[TBL] [Abstract][Full Text] [Related]
62. Barrett's esophagus: the metaplasia-dysplasia-carcinoma sequence: morphological aspects.
Geboes K
Acta Gastroenterol Belg; 2000; 63(1):13-7. PubMed ID: 10907313
[TBL] [Abstract][Full Text] [Related]
63. 'Senescence-associated' beta-galactosidase activity in the upper gastrointestinal tract.
Going JJ; Stuart RC; Downie M; Fletcher-Monaghan AJ; Keith WN
J Pathol; 2002 Apr; 196(4):394-400. PubMed ID: 11920734
[TBL] [Abstract][Full Text] [Related]
64. Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects.
Craanen ME; Offerhaus GJ; Tytgat GN
Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):147-64. PubMed ID: 8995119
[TBL] [Abstract][Full Text] [Related]
65. Characterization of metaplastic and heterotopic epithelia in the human gastrointestinal tract by the expression pattern of acyl-CoA synthetase 5.
Gassler N; Obermüller N; Keith M; Schirmacher P; Autschbach F
Histol Histopathol; 2005 Apr; 20(2):409-14. PubMed ID: 15736044
[TBL] [Abstract][Full Text] [Related]
66. [Reproducibility of histological criteria of dysplasia in Barrett mucosa].
Sagan C; Fléjou JF; Diebold MD; Potet F; Le Bodic MF
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D31-4. PubMed ID: 8013780
[TBL] [Abstract][Full Text] [Related]
67. Diversity counts. Visualizing pretumor progression in the gastrointestinal tract.
Langeveld D; Jansen M; Brosens L; Morsink F; Offerhaus GJ; de Leng W
Am J Clin Pathol; 2011 Jun; 135(6):878-88. PubMed ID: 21571961
[TBL] [Abstract][Full Text] [Related]
68. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
Lynch HT; Brand RE; Locker GY
Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
[TBL] [Abstract][Full Text] [Related]
69. Polyps in the gastrointestinal tract: discrepancy between endoscopic forceps biopsies and resected specimens.
Sung HY; Cheung DY; Cho SH; Kim JI; Park SH; Han JY; Park GS; Kim JK; Chung IS
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):190-5. PubMed ID: 19092673
[TBL] [Abstract][Full Text] [Related]
70. Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics.
Reibel J
Crit Rev Oral Biol Med; 2003; 14(1):47-62. PubMed ID: 12764019
[TBL] [Abstract][Full Text] [Related]
71. [Precancerous lesions in the gastrointestinal tract].
Hermanek P
Fortschr Med; 1978 Jan; 96(3):108-10. PubMed ID: 23348
[TBL] [Abstract][Full Text] [Related]
72. Problems arising from eastern and western classification systems for gastrointestinal dysplasia and carcinoma: are they resolvable?
Riddell RH; Iwafuchi M
Histopathology; 1998 Sep; 33(3):197-202. PubMed ID: 9777384
[TBL] [Abstract][Full Text] [Related]
73. [Tumor microenvironment in gastrointestinal tumors].
Etschmann B; Gattenlöhner S
Pathologe; 2011 Nov; 32 Suppl 2():321-5. PubMed ID: 22033687
[TBL] [Abstract][Full Text] [Related]
74. Telomere dysfunction and DNA damage checkpoints in diseases and cancer of the gastrointestinal tract.
Rudolph KL; Hartmann D; Opitz OG
Gastroenterology; 2009 Sep; 137(3):754-62. PubMed ID: 19619548
[No Abstract] [Full Text] [Related]
75. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.
Corfield AP; Myerscough N; Longman R; Sylvester P; Arul S; Pignatelli M
Gut; 2000 Oct; 47(4):589-94. PubMed ID: 10986224
[No Abstract] [Full Text] [Related]
76. How are the expression patterns of gut antimicrobial peptides modulated by human gastrointestinal diseases? A bridge between infectious, inflammatory, and malignant diseases.
Dias Bastos PA; Lara Santos L; Pinheiro Vitorino RM
J Pept Sci; 2018 Mar; 24(3):. PubMed ID: 29542263
[TBL] [Abstract][Full Text] [Related]
77. Molecular biology of dysplasia and cancer in inflammatory bowel disease.
Itzkowitz SH
Gastroenterol Clin North Am; 2006 Sep; 35(3):553-71. PubMed ID: 16952740
[TBL] [Abstract][Full Text] [Related]
78. [Evaluation of dysplasia in gastrointestinal diseases].
Salas Caudevilla A
Gastroenterol Hepatol; 2007 Dec; 30(10):602-11. PubMed ID: 18028857
[TBL] [Abstract][Full Text] [Related]
79. [Gentic factors in gastrointestinal diseases].
McConnell RB
Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):1-10. PubMed ID: 663378
[No Abstract] [Full Text] [Related]
80. SIRT1 is a useful biomarker for high-grade dysplasia and carcinoma in Barrett's esophagus.
Zhang S; Wang XI
Ann Clin Lab Sci; 2013; 43(4):373-7. PubMed ID: 24247792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
